Abstract
Sotalol caused similar proportional changes in ventricular effective refractory period at both 600 and 300 ms cycle lengths. There is no evidence for clinically significant reverse-use dependence on ventricular refractoriness at normal versus rapid heart rates in the intact human heart.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
